ENDLOS-TURBO PUT - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 03:35:13 2024-07-16 pm EDT | ||
| 4.05 EUR | -4.93% |
|
| Current month | +11.78% | ||
| 1 month | +19.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 4.08 | -4.23% |
| 24-07-15 | 4.26 | +19.33% |
| 24-07-12 | 3.57 | +19.40% |
| 24-07-11 | 2.99 | -12.32% |
| 24-07-10 | 3.41 | -8.33% |
Real-time Boerse Frankfurt Warrants
Last update July 16, 2024 at 03:35 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ8BSW |
| ISIN | DE000DJ8BSW2 |
| Date issued | 2024-01-10 |
| Strike | 265.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.588 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.35 € |
|---|---|
| Lowest since issue | 1.03 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
225
USD
Average target price
281.2
USD
Spread / Average Target
+24.96%
- Stock Market
- Certificates
- Certificat
